Companies

Illumina

Illumina dominates the DNA sequencing market with approximately 80% market share. Its sequencing platforms have driven the cost of genome sequencing down by orders of magnitude, enabling the genomics revolution in research and clinical diagnostics.

Details

Industry

Biotech

R&D Spend

$1.1B